Crohn's patients who lost drug response may benefit from higher doses
NCT ID NCT04245215
First seen Apr 16, 2026 · Last updated May 02, 2026 · Updated 4 times
Summary
This study looked at 108 adults with Crohn's disease whose symptoms returned while on the standard dose of ustekinumab. Researchers tested whether giving a stronger re-induction dose followed by either the usual or more frequent maintenance shots could bring back control. The goal was to see if patients could achieve remission without steroids and with lower inflammation markers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ingrid Arijs
Zaventem, 1930, Belgium
Conditions
Explore the condition pages connected to this study.